个人简介:
南华大学附属第二医院,副主任医师,普外科/乳甲外科副主任(主持工作)/硕士研究生导师,湖南省乳甲疾病防治临床医学研究中心负责人。
专业擅长:
主要研究方向:乳腺甲状腺疾病的综合防治,对本专业疾病具有丰富的经验,每年完成各类乳腺、甲状腺良恶性疾病的外科手术治疗1000余台次,擅长乳腺良性肿瘤微创手术,乳腺癌保乳术、改良根治术,乳腺癌术后I/II期乳房重建术,甲状腺良恶性肿瘤腔镜手术(经口腔前庭/全乳晕/腋窝)、小切口开放性手术、甲状腺微波消融术。
学术成果:
主持项目:
1.2015年度《基于生物可降解支架改良的细胞辅助脂肪移植术的研究》,衡阳市科技计划项目,项目编号:2015KJ50,主持,已结题;
2.T3期乳腺癌NACT后反应区内残留肿瘤细胞的评估与保乳手术决策的研究,湖南省科技厅临床医疗技术创新引导项目,项目编号:2018SK51511,主持,结题
3.乳腺癌患者新辅助化疗后利用3D打印手术导板引导保乳术的临床研究,湖南省卫生健康委科研计划项目,20201969,主持,在研
4.局部晚期乳腺癌个性化精准诊疗系统的建立,湖南省重点研发项目,2020SK2093,子课题主持,在研
5.乳腺良性肿瘤微创治疗技术临床应用与推广,湖南省卫健委适宜技术推广项目,202218015898,主持,在研
论文:
1.Li W, Fang K, Chen J, Deng J, Li D and Cao H (2023) The application of clinical variable-based nomogram in predicting overall survival in malignant phyllodes tumors of the breast. Front. Genet. 14:1133495. doi: 10.3389/fgene.2023.1133495(通讯作者)
2.Jie Luo,Deming Wang,Wenqiang Guo,Hong Cao∗Anesthesia Effect of Propofol Nanoinjection Combined with Nerve Block.Nanoscience and Nanotechnology Letters.Volume 12, Number 4, April 2020, pp. 512-517(6).(通讯作者)
3.Luo J, Chen F, Cao H, Zhu W, Deng J, Li D, Li W, Deng J, Zhong Y, Feng H, et al. Customised 3D-Printed Surgical Guide for Breast-Conserving Surgery after Neoadjuvant Chemotherapy and Its Clinical Application. Bioengineering. 2023; 10(11):1296. https://doi.org/10.3390/bioengineering10111296(通讯作者)
4.Wang, S., Deng, L., Chen, J., Li, Y., Zhong, Y., Wang, Y., & Cao, H. (2023). Role and efficacy of capecitabine in the anthracycline-free regimen in breast cancer patients: a systematic review and meta-analysis. Journal of cancer research and clinical oncology, 10.1007/s00432-023-05459-7. Advance online publication. https://doi.org/10.1007/s00432-023-05459-7(通讯作者)
5.Deng J, Liao X, Cao H. Neuroendocrine tumors in a patient with multiple endocrine neoplasia type 1 syndrome: A case report and review of the literature. Medicine (Baltimore). 2023 Jul 21;102(29):e34350. doi: 10.1097/MD.0000000000034350. PMID: 37478229.(通讯作者)
6.Xiaolong Zhu, Feng Chen, Hong Cao∗, Ling Li, Ning He, Xiaoxiao Han.Design and fused deposition modeling of triply periodic minimal surface scaffolds with channels and hydrogel for breast reconstruction. Int J Bioprint 2023, 9(2); doi: 10.18063/ijb.685.(并列第一作者)
7.Huang G, Cao H∗, Liu G, Chen J. Role of androgen receptor signaling pathway-related lncRNAs in the prognosis and immune infiltration of breast cancer. Sci Rep. 2022 Nov 30;12(1):20631. doi: 10.1038/s41598-022-25231-0. PMID: 36450882; PMCID: PMC9712677.(并列第一作者)